Founded in 2023, Holi operates a mobile-first digital clinic that unites doctors, psychodietitians, psychologists and physiotherapists to treat obesity at its root causes. Its platform continuously analyzes patient data to fine-tune therapy, integrates GLP-1 drug tracking, and triggers human intervention only when needed, which lowers medication costs by up to 50%. Patients reportedly achieve an average 17 % body-weight reduction after 12 months—about 1.5× better than drug therapy alone. The service is sold on a subscription model and gives users access to medications such as Ozempic and Wegovy alongside behavioral coaching. With fresh capital, Holi plans to enhance diagnostics integration, automate care processes, and add engagement features to sustain motivation. The company also intends to expand beyond Poland into Southern and Eastern European markets where telemedicine adoption is rising. Prior to the current round it raised a €680 k pre-Seed in 2023, demonstrating steady investor confidence in its hybrid care model.

Total raised

$4M

Funding rounds

2

Latest round

Seed

Latest activity

Nov 2025